Giulia Cerretti

Epidemiology, risk factors, and prognostic factors of gliomas

Alessia Pellerino, Mario Caccese, Marta Padovan et al. · Clinical and Translational Imaging · 2022 · 89 citations

Medicine, Neurosurgery, Oncology +14

Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study

Giuseppe Lombardi, Mario Caccese, Marta Padovan et al. · Cancers · 2021 · 50 citations · Full text

Medicine, Oncology, Pharmacology +16

Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)

Marta Padovan, Marica Eoli, Alessia Pellerino et al. · Cancers · 2021 · 31 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis

Marta Padovan, Marta Maccari, Alberto Bosio et al. · European Journal of Cancer · 2023 · 25 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients

Silvia Giunco, Marta Padovan, C. Angelini et al. · ESMO Open · 2023 · 23 citations · Full text

Medicine, Molecular Genetics, Oncology +17